europass - uniroma1.it...moretti c, vullo v, visca p, venditti m. bmc infect dis. 2015 sep...

15
Europass Curriculum Vitae Personal information First name(s) / Surname(s) First name(s) Surname(s) Maria Teresa Mascellino Address(es) Dept .of Public Health and Infect. Diseases, Policlinico Umberto1°viale del Policlinico 155, 00161 ROME (Italy) Telephone(s) +39-06-49970880 -49974075 Mobibe: +39-3281685935 Fax(es) +39-06-49972628 E-mail [email protected] Nationality Italian Date of birth 03/11/1949 Gender Female Occupational field Clinical Microbiology Work experience Dates -Unversity Affirmed Researcher (1981-2014) -Contract Employee Dept. Infectious and Tropical Diseases. at Policlinico Umberto 1° Rome (1975-1980) -Holder of Scholarshipat at Superior Institute of Sanitation in Rome (1973-1974) Occupation or position held Affirmed Researcher Main activities and responsibilities -Head of Bacteriology Laboratory in Infectious Diseases Department (1978-2008) -Executive Assistant at the UOC DLC08 “Special Microbiological Analyses” -Responsible of the Simple Operating Unit (SOU) “Miicrobiological analyses in the immunocompromised patients” ( 2011-2014) Name and address of employer University “La Sapienza” of ROME piazzale Aldo Moro 5 00185 ROME (Italy) Sector Clinical Microbiology (MED07 )

Upload: others

Post on 28-Jul-2020

0 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Europass - uniroma1.it...Moretti C, Vullo V, Visca P, Venditti M. BMC Infect Dis. 2015 Sep 30;15:393. doi: 10.1186/s12879-015-1133-3.PMID:26424078 7 ) Therapeutic strategy for pandrug-resistant

Europass Curriculum Vitae

Personal information

First name(s) / Surname(s) First name(s) Surname(s) Maria Teresa Mascellino

Address(es) Dept .of Public Health and Infect. Diseases, Policlinico Umberto1°viale del Policlinico 155, 00161 ROME (Italy)

Telephone(s) +39-06-49970880 -49974075 Mobibe: +39-3281685935

Fax(es) +39-06-49972628

E-mail [email protected]

Nationality Italian

Date of birth 03/11/1949

Gender Female

Occupational field Clinical Microbiology

Work experience

Dates -Unversity Affirmed Researcher (1981-2014) -Contract Employee Dept. Infectious and Tropical Diseases. at Policlinico Umberto 1° Rome (1975-1980) -Holder of Scholarshipat at Superior Institute of Sanitation in Rome (1973-1974)

Occupation or position held Affirmed Researcher

Main activities and responsibilities

-Head of Bacteriology Laboratory in Infectious Diseases Department (1978-2008) -Executive Assistant at the UOC DLC08 “Special Microbiological Analyses” -Responsible of the Simple Operating Unit (SOU) “Miicrobiological analyses in the immunocompromised patients” ( 2011-2014)

Name and address of employer University “La Sapienza” of ROME piazzale Aldo Moro 5 00185 ROME (Italy)

Sector Clinical Microbiology (MED07 )

Page 2: Europass - uniroma1.it...Moretti C, Vullo V, Visca P, Venditti M. BMC Infect Dis. 2015 Sep 30;15:393. doi: 10.1186/s12879-015-1133-3.PMID:26424078 7 ) Therapeutic strategy for pandrug-resistant

Education and training

Dates Attendance at Courses for Scientific collaborations abroad: - Trinity College University of Dublin (Ireland) (Erasmus Project) Teaching Staff Mobility for Sapienza University of Rome

March 2011 and September 2012 -University of New South Wales, Sidney (Australia) concerning Chlamydia trachomatis research September 2006

-Gen-Probe San Diego (California) concerning the amplified Mycobacterium tuberculosis Direct test October 2000

-Columbia Presbyterian Hospital of New York concerning the PCR of Mycobacterium tuberculosis and rapid bacterial diagnosis August 1994

-School of Pharmacy University of London concerning antibiotic resistances and SOS bacterial

response July 1992 and July 1993 .

-Institute Pasteur of Lyon (France) concerning water microbiology June 1975

Title of qualification awarded Degree in Biological Sciences, Specialization in Clinical Microbiology

Name and type of organisation providing education and

training

Sapienza University of ROME (Italy)

Personal skills and competences

Topics of interest: .Water microbiology, Bacterial antibiotic resistance and multidrug resistant microorganisms (MDR bacteria), Opportunistic infections in HIV-positive patients, Tuberculosis and Mycobacterium tuberculosis detection , disseminated mycobacteriosis, Chlamydia infections, MRSA (Methicillin Resistant Staphylococcus aureus ) and VRE ( Vancomycin Resistant Enterococcus) emergence , Rapid laboratory methods based on molecular biology (PCR), Helicobacter pylori: virulence determinants, pathology , heteroresistance, antibiotic susceptibility and therapy, Candidemiae:incidence in ICU (Intensive Care Units) and non ICU wards and relative resistance to antimycotics, Intracardiac devices infections, Sonication technique for bacterial biofilm, Synergistic activity of double carbapenem, Klebsiella pneumoniae MDR and Acinetobacter baumanni in nosocomial infections.

Mother tongue(s) Italian

Other language(s) 1)English 2) French

Self-assessment Understanding Speaking Writing

European level (*) Listening Reading Spoken interaction Spoken production

Language 1 very good 1 very good 1 very good 1 very good 1 very good

Language 2 good 2 good 2 good 2 good 2 good

(*) Common European Framework of Reference for Languages

Page 3: Europass - uniroma1.it...Moretti C, Vullo V, Visca P, Venditti M. BMC Infect Dis. 2015 Sep 30;15:393. doi: 10.1186/s12879-015-1133-3.PMID:26424078 7 ) Therapeutic strategy for pandrug-resistant

Additional information

Responsible of Faculty Researches promoted by Sapienza University of Rome about various scientific topics concerning the Clinical Microbiology and Infectious Diseases from 1981 to 1998 Participation to the following Research Projects: . Project of tuberculosis study organized by Superior Institute of Sanitation in Rome , Coordinator Antonio Cassone MD, 1995 -Project including the Mycobacterium avium-intracellulare infections in AIDS patients, Superior Institute of Sanitation in Rome, Coordinator Graziella Orefici MD, 1990-1995 -Project EARSS-ARISS about the bacterial resistances in clinical isolates from sepsis (Superior Institute of Sanitation in Rome),. Coordinator: Fortunato Paolo D’Ancona MD, 2001-2009

--Project about the multi-drug resistance in Mycobacterium tuberculosis (CNR-Rome), 2001

-Project concerning the paediatric respiratory infections, Policlinico Umberto 1° Rome,

Coordinator: Fabio Midulla MD, 2005 -Project concerning the immunologic methods and biomarkers for the rapid Mycobacterium tuberculosis diagnosis , Policlinico Umberto 1° Rome, Coordinator Prof. Claudio Mastroianni MD, 2006-2009, 2011-2012 -Project concerning the study of anti-retroviral drugs in HIV-positive patients, Policlinico Umberto 1° Rome,. Coordinator Prof. Vincenzo Vullo MD, 2010

- Project concerning the Role of biomarkers on the management of the active and latent tuberculosis,

Rome, Coordinator Prof C. Mastroianni 2011-2012

- Project "Screening and monitoring of latent tuberculosis in patients eligible for treatment with anti-TNF biologics: in vivo and in vitro analysis of T multifunctional cell-mediated response ” Policlinico Umberto I° Roma Coordinator Prof C. Mastroianni 2013 - Project "Screening, treatment and monitoring of latent tuberculosis in patients undergone treatment with biologics anti-TNF: in vivo and in vitro flow cytometric analysis of T multifunctional cellular response" Policlinico Umberto I° Roma Coordinator Prof C. Mastroianni 2014 Coordinator of Project “Intracardiac Devices Infections” for the research start up of young researchers 2013-2014

-Member of the Delegation of Sapienza University of Rome that went to Australasia on September 2006 in order to promote the relationships between Sapienza University of Rome and the different Australian Universities.

-Organization of three regional conferences respectively on Mycobacteria (11/5/1990), on Chlamydiae (19/03/1996) and on Helicobacter pylori (03/12/2003) held at Sapienza University of Rome - Member of the Committee of Association of Clinical Italian Microbiologists ( AMCLI ) for researches on Mycobacteria (CoSMic) , 1998-2003 - Member of the Committee of Association of Clinical Italian Microbiologists ( AMCLI ) for researches on antimicrobials (CoSA) for a correct identification of the carbapenemases - producing strains useful for the infections control(2013)

Foreign Contact Persons for scientific collaborations and years of attendance abroad -Prof. Richard Pinney, University of London (1992-1993) -Prof. Phyllis Della Latta, Columbia Presyterian Hospital of New York (1994) -Prof. Paul McMullin and Prof. Antonino Catanzaro, Gen-Probe San Diego and University of San Diego (California) (2000) -Prof. Samuel N,Breit, University of New South Wales (UNSW), Sidney (Australia) (2006) -Prof. Thomas Rogers, Trinity College University of Dublin (Ireland) (2011-2012)

Member of the following Scientific Society: -Italian Clinical Microbiology Association (AMCLI) -Italian Society of Microbiology (SIM) -European Society of Clinical Microbiology and Infectious Diseases (ESCMID) -American Microbiology Society (AMS) -New York Academy of Sciences -Healthcare Advisory Board (HAB) Participation as speaker to many national and international conferences

Page 4: Europass - uniroma1.it...Moretti C, Vullo V, Visca P, Venditti M. BMC Infect Dis. 2015 Sep 30;15:393. doi: 10.1186/s12879-015-1133-3.PMID:26424078 7 ) Therapeutic strategy for pandrug-resistant

Referee for many important International Journals (i.e. JAM etc. ) and for the Research Projects of the Ministry of University and Scientific Research (MIUR)

Referee at Fund for the control Infectious Diseases (RFCD) of Hong Kong for the revisions of Research Projects

Her biography is included in Who’s who in Science and Engineering IV e V Edition (1998-1999 e 2000-2001) , in Who’s Who in Medicine and Healthcare new millenium edition (III Edition) 2000, in Who’s who in the World XXVII Edition 2010 (The Marquis Who’s Who Publication Board) and in The Barons 500 Edition 2000

Teaching activity

CdL CFU

1) Scienze Infermieristiche Pomezia (Rome) Clinical Microbiology

2

2) Scienze Infermieristiche (ADE) Pomezia (Rome) Sexual Diseases

1

3) Tecnico Radiologo Sabina Universitas – Rieti Clinical Microbiology

2

4) Tecnico Laboratorio Biomedico Policlinico Umberto 1° - Rome Clinical microbiology

2

5) Obstetrics Policlinico Umberto 1° - Rome Infectious Diseases

2

6) Scienze Infermieristiche Policlinico Umberto 1° - Rome Clinical Microbiology

2

TOTAL 11 Other teaching activity

1) Specialization Course in Infectious Diseases (1981-2014)

2) Teaching in Ph.D. in Public Health and Infectious Diseases

T P EERASMUS Project from Sapienza University of Rome in Teaching Staff Mobility at DUBLIN TRINITY COLLEGE in DDublin (Ireland) for a series of lessons of Clinical Microbiology to Medicine students in March 2011 and September 22012

Page 5: Europass - uniroma1.it...Moretti C, Vullo V, Visca P, Venditti M. BMC Infect Dis. 2015 Sep 30;15:393. doi: 10.1186/s12879-015-1133-3.PMID:26424078 7 ) Therapeutic strategy for pandrug-resistant

LIST OF PRINCIPAL PUBBLICATIONS

1) Severe bloodstream infection due to KPC-producer E. coli in a renal transplant recipient

treated with the double-carbapenem regimen and analysis of in-vitro synergy testing: a case report

Oliva, A. Cipolla, F. Gizzi, A. D’Abramo, M. Favaro, Massimiliano De Angelis, G. Ferretti, G.

Russo, M. Iannetta, C.M. Mastroianni, M.T. Mascellino, V. Vullo

Medicine in press 2015

2) Bactericidal and synergistic activity of double-carbapenem regimen for infection caused by

carbapenemase-producing Klebsiella pneumoniae

Oliva A., Gizzi F.,.Mascellino MT., Cipolla A.,D’Abramo A., D’Agostino C., Trinchieri V., Russo

G., Tierno F., Iannetta M., Mastroianni CM.,Vullo V.

Clin Microbiol Infect.(CMI) 2015 Sep 23. pii: S1198-743X(15)00869-1. doi:

10.1016/j.cmi.2015.09.014.

PMID:26409059

3) Epidemiology of Staphylococcus aureus in Italy: first nationwide survey, 2012

Campanile F., Bongiorno D., Perez M., Mongelli G.,Sessa L., Benvenuto , Gona B

AMCLI – S. aureus Survey Participants Mascellino MT: et al

JGAR 2015, 169; 1-8 ISSN 2213-7165 Elsevier

4) Helicobacter pylori infection: susceptibility to antimicrobials and eradication rate in pluritreated

pangastritis patients.

Mascellino MT., Oliva A., De Angelis M., Porowska B.

Ind J Appl Res 2015 vol 5 (4), 30-32.ISSN 2249-555X doi10.15373/2249555X

5) Ebola virus epidemiology in West Africa

Mascellino MT., De Angelis M., Borgese L.

J J Epidemiol Prevent. 2015, 1(2): 014. ISSN 2381-487X

6) The role of vancomycin in addition with colistin and meropenem against colistin-sensitive

multidrug resistant Acinetobacter baumannii causing severe infections in a Paediatric Intensive

Care Unit.

Ceccarelli G, Oliva A, d'Ettorre G, D'Abramo A, Caresta E, Barbara CS, Mascellino MT, Papoff P,

Moretti C, Vullo V, Visca P, Venditti M.

BMC Infect Dis. 2015 Sep 30;15:393. doi: 10.1186/s12879-015-1133-3.PMID:26424078

7) Therapeutic strategy for pandrug-resistant Klebsiella pneumoniae severe infections: short-course

treatment with colistin increases the in vivo and in vitro activity of double carbapenem regimen.

Oliva A, Mascellino MT, Cipolla A, D'Abramo A, De Rosa A, Savinelli S, Ciardi MR, Mastroianni

CM, Vullo V.

Int J Infect Dis. 2015 Apr;33:132-4. doi: 10.1016/j.ijid.2015.01.011. Epub 2015 Jan 15.

PMID:25597275

8) Synergistic activity and effectiveness of a double-carbapenem regimen in pandrug-resistant

Klebsiella pneumoniae bloodstream infections.

Oliva A, D'Abramo A, D'Agostino C, Iannetta M, Mascellino MT, Gallinelli C, Mastroianni CM,

Vullo V

.J Antimicrob Chemother. 2014 Jun;69(6):1718-20. doi: 10.1093/jac/dku027. Epub 2014 Feb 11.

PMID:24521856

9) Study of methicillin-resistant Staphylococcus aureus (MRSA) carriage in a population of HIV-

negative migrants and HIV-infected patients attending an outpatient clinic in Rome.

Oliva A, Lichtner M, Mascellino MT, Iannetta M, Ialungo AM, Tadadjeu Mewamba S, Pavone P,

Mengoni F, Mastroianni CM, Vullo V.

Ann Ig. 2013 Mar-Apr;25(2):99-107. doi: 10.7416/ai.2013.1911.PMID:23471447

Page 6: Europass - uniroma1.it...Moretti C, Vullo V, Visca P, Venditti M. BMC Infect Dis. 2015 Sep 30;15:393. doi: 10.1186/s12879-015-1133-3.PMID:26424078 7 ) Therapeutic strategy for pandrug-resistant

10) Sonication of explanted cardiac implants improves microbial detection in cardiac device

infections. Oliva A, Nguyen BL, Mascellino MT, D'Abramo A, Iannetta M, Ciccaglioni A, Vullo

V,Mastroianni CM

J Clin Microbiol. 2013 Feb;51(2):496-502. doi: 10.1128/JCM.02230-12. Epub 2012 Nov

28.PMID:23196364

11) Letter: Surveillance of Helicobacter pylori antibiotic resistance.

Porowska B, Mascellino MT, Severi C.

Aliment Pharmacol Ther. 2012 Dec;36(11-12):1102; author reply 1103. doi: 10.1111/apt.12070.

PMID:23130773

12) Lactococcus garvieae endocarditis in a patient with colonic diverticulosis: first case report in

Italy and review of the literature.

Russo G, Iannetta M, D'Abramo A, Mascellino MT, Pantosti A, Erario L, Tebano G, Oliva A,

D'Agostino C, Trinchieri V, Vullo V.

New Microbiol. 2012 Oct;35(4):495-501. Epub 2012 Oct 1. Review.PMID:23109019

13) Candidaemia in immune-compromised host: incidence and drug susceptibility.

Mascellino M.T., Raponi G., Oliva A., Mastroianni C.M., Vullo V.

J Clin Exp Pathol 2012; 2(7): 1-5 doi: 10.4172/2161-0681.1000131 ISSN 2161-0681

14) Immunopathogenesis in Chlamydia trachomatis Infected Women.

Mascellino MT, Boccia P, Oliva A.

ISRN Obstet Gynecol. 2011;2011:436936. doi: 10.5402/2011/436936. Epub 2011 Nov

24.PMID:22191045

15) In vitro downregulation of matrix metalloproteinase-9 in rat glial cells by CCR5 antagonist

maraviroc: therapeutic implication for HIV brain infection.

Gramegna P, Latronico T, Branà MT, Di Bari G, Mengoni F, Belvisi V, Mascellino MT, Lichtner

M, Vullo V, Mastroianni CM, Liuzzi GM.

PLoS One. 2011;6(12):e28499. doi: 10.1371/journal.pone.0028499.Epub 2011 Dec8

PMID:22174822

16) Prevalence of methicillin-resistant staphylococci isolated from different biological samples at

Policlinico Umberto I of Rome: correlation with vancomycin susceptibility

Mascellino M.T., Oliva A.,Notarnicola R, Gallinelli C, Chiarini F. Microbiol Med 2011; 26(1):71-

73 doi: 10.4081 eISSN 2280-6423

17) Impact of Helicobacter pylori resistance in unsuccessfully pluritreated patients in a Department

of Infectious Disease in Rome Mascellino M.T., Porowska B., Oliva A., Boccia P., Severi C.,

Microbiol. Res 2010; 2(2): 9-14 eISSN 2036-7481

18) Pacemaker lead endocarditis due to multidrug-resistant Corynebacterium striatum detected with

sonication of the device.

Oliva A, Belvisi V, Iannetta M, Andreoni C, Mascellino MT, Lichtner M, Vullo V, Mastroianni

CM.

J Clin Microbiol. 2010 Dec;48(12):4669-71. doi: 10.1128/JCM.01532-10. Epub 2010 Oct

13.PMID:20943861

19) Helicobacter pylori: determinant and markers of virulence.

Mascellino MT, Margani M, Oliva A.

Dis Markers. 2009;27(3):137-56. doi: 10.3233/DMA-2009-0658. Review.PMID:19893209

20) Primary retroperitoneal abscesses due to Rhodococcus equi in a patient with severe nephrotic

syndrome: successful antibiotic treatment with linezolid and tigecycline.

Russo G, Lichtner M, Carnevalini M, Mascellino MT, Mengoni F, Oliva A, Miccoli GA, Iannetta

M, Trinchieri V, Massetti AP, Mastroianni CM, Vullo V.

Int J Infect Dis. 2010 Jun;14(6):e533-5. doi: 10.1016/j.ijid.2009.06.021. Epub 2009 Sep

15.PMID:19758832

Page 7: Europass - uniroma1.it...Moretti C, Vullo V, Visca P, Venditti M. BMC Infect Dis. 2015 Sep 30;15:393. doi: 10.1186/s12879-015-1133-3.PMID:26424078 7 ) Therapeutic strategy for pandrug-resistant

21) Chlamydia trachomatis detection in a population of asymptomatic and symptomatic women:

correlation with the presence of serological markers for this infection.

Mascellino MT, Ciardi MR, Oliva A, Cecinato F, Hassemer MP, Borgese L.

New Microbiol. 2008 Apr;31(2):249-56.PMID:18623991

22) Atypical localization of Leishmaniasis in an intestinal polyp.

Zaffiri L, d'Ettorre G, Massetti AP, Mascellino MT, Mastroianni CM, Vullo V.

Infection. 2008 Mar;36(2):187-8. doi: 10.1007/s15010-007-7038-3. Epub 2008 Mar 10. .

PMID:18327682

23) GD3 nuclear localization after apoptosis induction in HUT-78 cells.

Tempera I, Buchetti B, Lococo E, Gradini R, Mastronardi A, Mascellino MT, Sale P, Mosca L,

d'Erme M, Lenti L.

Biochem Biophys Res Commun. 2008 Apr 11;368(3):495-500. doi: 10.1016/j.bbrc.2007.12.196.

Epub 2008 Feb 7.PMID:18261989

24) Activity of D-carnitine and its derivatives on Trypanosoma infections in rats and mice.

Manganaro M, Mascellino MT, Gradoni L.

Parasite. 2003 Jun;10(2):147-51.PMID:12847922

25) Association of cellular prion protein with gangliosides in plasma membrane microdomains of

neural and lymphocytic cells.

Mattei V, Garofalo T, Misasi R, Gizzi C, Mascellino MT, Dolo V, Pontieri GM, Sorice M, Pavan

A.

Neurochem Res. 2002 Aug;27(7-8):743-9.PMID:12374209

26) Reduced bactericidal activity against Staphylococcus aureus and Pseudomonas aeruginosa of

blood neutrophils from patients with early adult respiratory distress syndrome.

Mascellino MT, Delogu G, Pelaia MR, Ponzo R, Parrinello R, Giardina A.

J Med Microbiol. 2001 Jan;50(1):49-54.PMID:11192505

27) Chlamydia pneumoniae infection and PFO-associated ischemic stroke.

Rasura M, Anzini A, Mascellino MT.

Stroke. 2000 Oct;31(10):2519-21. No abstract available. PMID:11022089

28) Antimicrobial investigation of semipurified fractions of Ginkgo biloba leaves.

Mazzanti G, Mascellino MT, Battinelli L, Coluccia D, Manganaro M, Saso L.

J Ethnopharmacol. 2000 Jul;71(1-2):83-8.PMID:10904149

29) Antimicrobial activity of fluoroquinolones and other antibiotics on 1,116 clinical Gram-positive

and Gram-negative isolates.

Mascellino MT, Farinelli S, Iegri F, Iona E, De Simone C.

Drugs Exp Clin Res. 1998;24(3):139-51.PMID:9825230

30) The influence of the SOS response on the activity of 4-quinolones and zidovudine against some

strains of Enterobacteria.

Mascellino MT, Farinelli S, Iegri F, Iona E.

New Microbiol. 1998 Jan;21(1):31-40.PMID:9497927

31) Antimicrobial Activity of Ginsenosides

L.Battinelli,M.T. Mascellino,M.C. Martino,M. Lu and G.Mazzanti

Pharm.Pharmacol Com 1998, 4: 411-413 ISSN 2042-7158

32) Killing of Pseudomonas aeruginosa isolated from patients with critical post-operative

complications. Effect of various antibiotics.

Delogu G, Iona E, Amati F, Marandola M, Costantini D, Baumgartner IM, Mascellino MT.

Ann Ital Chir. 1997 Mar-Apr;68(2):219-24. . PMID:9290013

33) Un caso di Difterite tracheobronchiale. Tracheobronchial Diphteria a case report.

M.G. Vigili., O.Palma., G.Maggi, M.T. Mascellino e F.Iegri.

Otorinolaringol 1997 ; 47:27-32 ISSN 0042-4668

Page 8: Europass - uniroma1.it...Moretti C, Vullo V, Visca P, Venditti M. BMC Infect Dis. 2015 Sep 30;15:393. doi: 10.1186/s12879-015-1133-3.PMID:26424078 7 ) Therapeutic strategy for pandrug-resistant

34) Incidence of bacterial colonization in the throat and in urines at paediatric age with evaluation

of sensitivity to common antibiotics.

Catania S, Mascellino MT, Ajassa C, Berardelli G, Bellagamba R, Tzanzoglou S, Iegri F, Ronchetti

MP, Catania N. Riv Eur Sci Med Farmacol. 1996 Jul-Aug;18(4):169-72.PMID:9177617

35) Antimicrobial activity of Calluna vulgaris

Braghiroli L., Mazzanti G., Manganaro M:,Mascellino M.T., Vespertilli T.

Phytotherapy Research 1996 ;10 : 586 – 588 ISSN 1099-1573

36) Type frequency and antimicrobial susceptibility of Mycobacterium avium-intracellulare

complex strains isolated in Italy from AIDS and non-AIDS patients.

Fattorini L, Vincent V, Li B, Xiao Y, Varnerot A, Tortoli E, Piersimoni C, Mandler F, Mascellino

MT, Iona E, Orefici G.

J Chemother. 1996 Feb;8(1):37-42.PMID:8835106

37) Rhodococcus equi Virulence-Associated Antigens and Specific Antibody Response in AIDS

Patients Infected with R. equi.

Mastroianni CM, Lichtner M, Mengoni F, Mascellino MT, Vullo V, Delia S.

Clin Microbiol Infect. 1995 Sep;1(1):18-23.PMID:11866716

38) Activity of seven antimicrobial agents, alone and in combination, against AIDS-associated

isolates of Mycobacterium avium complex.

Piersimoni C, Tortoli E, Mascellino MT, Passerini Tosi C, Sbaraglia G, Mandler F, Bistoni F,

Bornigia S, De Sio G, Goglio A, et al.

J Antimicrob Chemother. 1995 Sep;36(3):497-502.PMID:8830013

39) An imported fatal case of diphtheria in Italy.

von Hunolstein C, Efstratiou A, La Valle R, Gentili G, Pestalozza S, Mascellino MT, Rappuoli R,

Orefici G, Cassone A.

Eur J Clin Microbiol Infect Dis. 1995 Sep;14(9):828-30. PMID:8536739

40) Rapid detection of mycobacteria by combining a radiometric detection system with DNA

probes.

Mascellino MT, Rossi F, Iegri F, Iona E. New Microbiol. 1994 Jul;17(3):249-53.PMID:7968660

41) Stafilococchi coagulase negative(SCN) da emocolture in pazienti con infezione da

HIV[Coagulase-negative Staphylococci isolated in blood sample taken from HIV-infected patients

U.Visco Comandini,S. Farinella,A.Salotti,F.Ferri,U.Ferone,E.Iona,M.T.Mascellino,F.Sorice

Giorn Mal Inf Parass 1994; 46: 783 - 786

42) Infections due to Rhodococcus equi in three HIV-infected patients: microbiological findings

and antibiotic susceptibility.

Mascellino MT, Iona E, Ponzo R, Mastroianni CM, Delia S.

Int J Clin Pharmacol Res. 1994;14(5-6):157-63.PMID:7672872

43) In vitro activity of zidovudine alone and in combination with ciprofloxacin against Salmonella

and Escherichia coli.

Mascellino MT, Iona E, Iegri F, De Gregoris P, Farinelli S.

FEMS Immunol Med Microbiol. 1993 Jun;7(1):23-8.PMID:8364519

44) Clinical-therapeutic considerations in a case of miliary tuberculosis in an indonesian girl.

Ajassa C, Angelici AM, Rendina E, Trinchieri V, Berardelli G, Bellagamba R, Catania N, Falciano

M, Mascellino MT, Causo T, et al.

Riv Eur Sci Med Farmacol. 1993 May-Aug;15(3-4):175-80.. PMID:7761666

45) Activity of antimicrobial agents against Mycobacterium avium-intracellulare complex (MAC)

strains isolated in Italy from AIDS-patients.

Fattorini L, Hu CQ, Jin SH, Santoro C, Tsang AY, Mascellino MT, Mandler F, Orefici G.

Zentralbl Bakteriol. 1992 Apr;276(4):512-20.PMID:1611208

Page 9: Europass - uniroma1.it...Moretti C, Vullo V, Visca P, Venditti M. BMC Infect Dis. 2015 Sep 30;15:393. doi: 10.1186/s12879-015-1133-3.PMID:26424078 7 ) Therapeutic strategy for pandrug-resistant

46) Plasmids as epidemiologic markers in nosocomial Gram-negative bacilli: experience in an

intensive care unit.Mascellino MT, Iona E, Farinelli S, Iegri F, Marandola M, Pennacchiotti ML,

Cascioli C, Visco Comandini U, De Logu G.

Drugs Exp Clin Res. 1992;18(4):121-8.PMID:1333401

47) In vitro activity of clarithromycin alone or in combination with other antimicrobial agents

against Mycobacterium avium-intracellulare. Complex strains isolated from AIDS patients.

Mascellino MT, Iona E, Fattorini L, De Gregoris P, Hu CQ, Santoro C, Orefici G.

J Chemother. 1991 Dec;3(6):357-62.PMID:1840274

48) Salmonellosi non tifoidee nell’infezione da HIV

S.Catania,M.Ciardi,F.Rossi,C.Nobili,C.M.Mastroianni,C.Lanzalone,V.Trincheri,M.T.Mascellino,

T. Causo, A.Cirelli

Giorn Mal Inf Parass 1991; 43: 23 -26

49) Evaluation of vaginal microflora in patients infected with HIV.

Mascellino MT, Iona E, Iegri F, Catania S, Trinchieri V, Oliva P, Amenta L, Revérberi L, Sorice F.

Microbiologica. 1991 Oct;14(4):343-9.PMID:1775091

50) Cryptococcal meningitis and toxoplasma encephalitis in an AIDS patient.

Catania S, Nobili C, Trinchieri V, Mascellino MT, Cirelli A.

Acta Neurol (Napoli) 1990 Feb;12(1):82-4.PMID:2336999

51) Mycobacteria isolated in patients HIV+ and HIV-: comparison between radiometric procedures

and conventional methods.

Mascellino MT., De Gregoris P., Iegri F., Rossi F., Sorice F.

Ther Inf Dis 1990; 5(1): 27-38

52) Polycystic ovary syndrome: obesity, insulin resistance, hyperandrogenism.

Lo Dico G, Alongi G, Savatteri L, Rini GB, Mascellino MT, Di Fede G, Rizzo G.

Acta Eur Fertil. 1989 Sep-Oct;20(5):309-13.PMID:2700062

53) Three severe relapsing herpes labialis treated with thymopentine.

Affronti M, Malta R, Di Rosa S, Scardavi M, Mascellino MT, Vassallo L, Renda M, Amico ME,

Rini GB.

J Chemother. 1989 Jul;1(4):1109.. PMID:16312793

54) Plasmid profile as epidemiological marker for Pseudomonas aeruginosa in an intensive care

unit.

Mascellino MT, Iegri F, Delogu G, Catania S, Sorice F.

J Chemother. 1989 Jul;1(4):401-3.. PMID:16312459

55) Phagocytosis and killing of A-protein positive Staphylococcus aureus in the presence of low

doses of antibiotics.

Mascellino MT, De Vito ML, Maclean Feeney E, Iegri F, Catania S.

Drugs Exp Clin Res. 1989;15(2):63-9.PMID:2737081

56) Significant bacteriological findings in HIV-positive patients.

Mascellino MT, De Sanctis GM, Iegri F, De Gregoris P, Sorice F.

Boll Ist Sieroter Milan. 1989;68(3):271-6.. PMID:2491436

57) Treatment with aztreonam of Gram-negative infections in patients seropositive for HIV.

Catania S, Mascellino MT, Trinchieri V, Musso R, Lorenzi A, Cirelli A.

Riv Eur Sci Med Farmacol. 1988 Aug;10(4):317-21.. PMID:3274906

58)Azione di macrolidi su fagocitosi e killing di germi Gram-positivi

De VitoM.L.,Mascellino M.T., De Bac C.

Microbiologia Medica 1988;.3(1): 5-9 ISSN 2280-6423

59) Erythromycin, miocamycin and clindamycin towards adhesivity and phagocytosis of Gram-

positive bacteria.

Mascellino MT, Catania S, De Vito ML, De Bac C.

Microbiologica. 1988 Jul;11(3):231-41.PMID:3262809

Page 10: Europass - uniroma1.it...Moretti C, Vullo V, Visca P, Venditti M. BMC Infect Dis. 2015 Sep 30;15:393. doi: 10.1186/s12879-015-1133-3.PMID:26424078 7 ) Therapeutic strategy for pandrug-resistant

60) Macrolidi e adesività batterica in vitro

M. L. De Vito., M.T. Mascellino., C.De Bac.

Farmaci e Terapia 1988; 1 (1):21-26 ISSN 0393-9693

61) Pattern of gastric acidity and gastrin blood level in basic conditions and following the

administration of food in subjects with ulcer-like and non ulcer-like dyspepsia.

Rotolo G, Di Fede G, Mascellino MT, Rizzo G, Scardavi M, Rini GB.

Panminerva Med. 1988 Jan-Mar;30(1):37-41.. PMID:3419851

62) Infezioni batteriche in pazienti anti – HIV positivi.

Cirelli A., S. Di Sabato., F.Bonanni., Mascellino M.T.

Giorn Mal Inf Parass 1988;.34:1273-1275

63) Serum lipoprotein pattern after SAMe-treatment.

Rini GB, Di Fede G, Rotolo G, Rizzo G, Mascellino MT, Affronti M, Delle Vedove G.

Boll Soc Ital Biol Sper. 1987 Oct 31;63(10):919-22. PMID:3447603

64) Clinical and bacteriological evaluation of miocamycin in some respiratory tract infections.

Catania S, Mascellino MT, Fornasiero M, Musso R.

Riv Eur Sci Med Pharm. 1987 Sep;9(3):323-5. PMID:3509889

65) Preliminary data of insulin "cephalic" secretory.

Rini GB, Di Fede G, Mascellino M, Rizzo G.

Boll Soc Ital Biol Sper. 1987 Jun 30;63(6):509-13.. PMID:3307841

66) In vitro activity of mezlocillin on bacterial adhesion, phagocytosis and haemoagglutination of

several anaerobic germs.

Mascellino MT, Lorenzi A, Bonanni M, De Vito ML.

Recenti Prog Med. 1987 Jun;78(6):255-9.. PMID:2889247

67) Microbiologic culture findings on intrauterine devices.

Maruotti T, Reverberi L, Loiacono G, Cecinato F, Porpora MG, Mascellino MT, Bresadola M.

Minerva Ginecol. 1987 May;39(5):361-5.. PMID:3306464

68) Complicanze infettive in soggetti operati alle vie biliari

MT. Mascellino, A. Lorenzi, P.Chirletti, ML. De Vito

Chir Epatobil 1987; 6: 31-35 ISSN 0393-1471

69) Trattamento delle infezioni da Gram-negativi con aztreonam in pazienti sieropositivi per HIV

Catania S., Mascellino MT., Trinchieri V., Musso R., Lorenzi A., Ferrazzi M., Nobili C., Cirelli A.

Giorn Mal Inf Parass 1987; 39: 1244-1248

70) Antimicrobial activity of norfloxacin in enteric and urinary tract infections: combined effect of

norfloxacin with aminoglycosides, tetracycline and chloramphenicol.

Mascellino MT, Lorenzi A, Bonanni M, Iegri F.

Drugs Exp Clin Res. 1986;12(4):319-23. PMID:3720519

71) Research on staphylococcal enterotoxin B by dot immunobinding assay (DIB). Preliminary

observations.

Vullo V, Mascellino MT, Contini C, Mastroianni CM, Massetti AP, Di Seri M.

Quad Sclavo Diagn. 1986 Dec;22(4):412-8. PMID:3671670

72) Associazione tra ceftazidime e aminoglicosidi nei confronti di Pseudomonas resistenti alle beta-

lattamine.

Mascellino M.T., Prignano G., Lorenzi A, Distefano G., Catania S.

Giorn Mal Inf Parass 1985; 37: 226 -.229

73) Ricerca del Campylobacter nelle Enteriti acute e suo ruolo eziopatogenetico

F.Rossi, M.T.Mascellino, F.Rendina, F.Mongiò, F.Traditi

Giorn Mal Inf Parass 1985; 37: 190 -193

74) Effect of norfloxacin in infections of the urinary and intestinal tracts: combined effects with

aminoglucosides and with tetracycline and chloramphenicol.

Mascellino MT, Lorenzi A, Bonanni M, Iegri F.

G Ital Chemioter. 1985 May-Aug;32(2):497-500.. PMID:3833594

Page 11: Europass - uniroma1.it...Moretti C, Vullo V, Visca P, Venditti M. BMC Infect Dis. 2015 Sep 30;15:393. doi: 10.1186/s12879-015-1133-3.PMID:26424078 7 ) Therapeutic strategy for pandrug-resistant

75) Azione del ceftazidime nei confronti degli Enterobatteri: confronto con gli aminoglicosidi ed

altre cefalosporine

M.T. Mascellino,G.Prignano,A.Lorenzi,F.Iegri,G.Distefano,S.Catania

Eur Rev Med & Pharm Sci 1984; 6: 1-4 ISSN 1128-3602

76) Combined surgical and medical treatment of pilonidal cysts and fistulae as prevention of

recurrence.

Iavarone C, Cappellano E, Felici A, Lorenzotti A, Mascellino MT, Bollino D, Pisciotti R.

Minerva Med. 1984 Nov 17;75(44):2687-90. PMID:6392938

77) A preliminary report on the immunological responses after oral vaccine (Ty 21a).

Sirianni MC, Turbessi G, Scarpati B, Russo G, Mascellino MT, Aiuti F.

Boll Ist Sieroter Milan. 1984 Sep;63(4):352-6.PMID:6394032

78) Evaluation of automatic antimicrobial susceptibility testing with the MS-2 system.

Mascellino MT, Prignano G, Lorenzi A, Iegri F, Catania S, Lancia O, Sorice F.

Boll Ist Sieroter Milan. 1984 May 31;63(2):104-10.PMID:6466451

79) Combined antibacterial activity of clavulanic acid with amoxicillin and ampicillin against

Gram-negative strains.

Mascellino MT, Prignano G, Lorenzi A, Iegri F, Martorano E, Catania S, Ginanni Corradini S.

Boll Ist Sieroter Milan. 1984;63(5):447-52. PMID:6335660

80) Confronto tra esame colturale e counter elettroforetico per la ricerca di Streptococcus

pneumoniae nell’ espettorato

M.T.Mascellino,M.Bonanni,C.Latella,C.Furlan,S.Ginanni Corradini

Giorn Mal Inf Parass 1983; 35: 1512 -1516

81) Infezioni da anaerobi: attività di alcuni agenti antimicrobici

M.T.Mascellino, D.Bollino, M.R. Pisciotta

Eur. Rev.Med. & Pharm. Sci 1983; 5, 311-316 ISSN 1128-3602

82) Sensibilità di ceppi di S.pneumoniae isolati in pazienti con polmonite pneumococcica

confrontati con nuovi antibiotici e con penicillina e tetraciclina

M.T. Mascellino, C.Latella, M. Bonanni, A. Spanò, S.Catania

Eur Rev Med & Pharm Sci 1983; 5: 535 – 538 ISSN 1128-3602

83) Attività in vitro di alcuni antibiotici nei confronti di diversi sierotipi di pneumococchi patogeni

M.T.Mascellino, M. Bonanni, C.Latella, D. Bollino, S. Ginanni Corradini

Giorn Mal Inf Parass. 1983; 35: 1508 -1511

84) La nostra esperienza sull’ attività in vitro delle cefalosporine di 3° generazione

M.T.Mascellino,G.Prignano,F.Legri,A.Lorenzi,F.Sorice,F.De Rosa,S.Ginnani Corradini

Giorn Mal Inf Parass 1983; 35:1501-1507

85) Infezioni da salmonelle minori: un caso con enterite e batteriemia da S. newport

Chircu LV., Mascellino MT., Lacava V.

Giorn Mal Inf Parass 1982; 35: 98-101

86) Clinico-microbiologic bases for the use of new cephalosporins.

De Bac C, Mascellino MT, Nuti M.

Minerva Med. 1982 Apr 7;73(15):899-903.. PMID:6979006

87) Clinical evalutation of Cefotaxime in different types of infection

Sorice F., Delia S,Mascellino M.T.,Vullo V.,Ferone U.

Drugs Exptl.Clin.Res Vlll(5) 1982 . 511-516 ISSN 0378-6501

88) Considerazioni cliniche su alcuni casi di infezione anaerobica

Clinical remarks on some cases of anaerobic infection

Mascellino M.T., Bollino D., Iegri F.,Rocco C., Chirletti P.

Giorn Mal Inf Parass 1982; 34: 1258- 1261

89) Studio sull’azione antibatterica in vitro di alcuni nuovi agenti chemioterapici

Giganti G., Iegri F., Mascellino M.T.

Giorn Mal Inf Parass 1982; 34: 216-.219

Page 12: Europass - uniroma1.it...Moretti C, Vullo V, Visca P, Venditti M. BMC Infect Dis. 2015 Sep 30;15:393. doi: 10.1186/s12879-015-1133-3.PMID:26424078 7 ) Therapeutic strategy for pandrug-resistant

90) Patogeni e saprofiti isolati in prelievi successivi nello stesso paziente:sensibilità agli antibiotici

Pathogenous and saprophyte bacteria isolates in following specimens in the same patient:sensitivity

to antibiotics

Mascellino M.T., Taranta B., Benedetti C., Selan L.

Giorn Mal Inf Parass 1982; 34: 118 -121

91) Prime osservazioni sulla tipizzazione di Pneumococchi isolati in soggetti con affezioni

respiratorie.Early remarks on typing of isolated Pneumococci from people affected by respiratory

diseases

Mascellino MT.,Taranta B., De Bac C.

Giorn Mal Inf Parass 1982; 34: 213- 215

92) Minimal inhibitory and bactericidal concentrations of cefoperazone, cefotaxime, cefuroxime

and cefalotin against 90 bacterial strains.

Mascellino MT, Prignano G, Iegri F, Lorenzi A.

Boll Ist Sieroter Milan. 1982;61(4):309-19. PMID:6100234

93) Resistenza batterica trasferibile in un ceppo di Salmonella agona, isolato in prelievi successivi

nello stesso paziente

Selan L.,Taranta B., Mascelino M.T.

Giorn Mal Inf Parass 1982; 34:1289 -1291

94) Study of the minimum inhibiting concentration of a new cephalosporin (HR 756): comparative

data with other beta-lactamic antibiotics.

Mascellino MT, Prignano G, Iegri F, Delia S.

Boll Ist Sieroter Milan. 1981 May;60(2):102-9. PMID:6272823

95) A multicentric study for serotyping and susceptibility to antibiotics of pneumococci in Italy.

De Bac C, Andreoni O, Fara GM, Giammanco G, La Placa M, Mascellino MT.

Ric Clin Lab. 1981 Apr-Jun;11(2):145-9.PMID:7268274

96) Comparative in vitro evaluation of various aminoglycosides.

Mascellino MT, Prignano G, Iegri F, Delia S.

G Ital Chemioter. 1981 Jan-Dec;28(1-2):47-54.. PMID:7347705

97) Comparative sensitivity of anaerobic germs to cephalosporins. Measurements of the minimum

inibitory concentrations and minimum bactericidal concentrations.

Mascellino MT, Bollino D, Rocco C, Latella C.

G Ital Chemioter. 1981 Jan-Dec;28(1-2):1-4.. PMID:7347701

98) Multicenter study on the distribution of Streptococcus pneumoniae strains in Italy.

De Bac C, Mascellino MT, Fara GM, Pagano M, La Placa M, Gatti M, Galluppi E, Giammanco G,

Santangelo C, Andreoni O, Fonio P.

Boll Ist Sieroter Milan. 1981;60(1):15-20. PMID:7272007

99) La resistenza multipla trasmissibile negli Enterobatteri:presenza di fattori di resistenza in

Salmonelle isolate presso l’Istituto di Malattie infettive dell’Università di Roma

Taranta B., Selan L., Mascellino M.T., Benedetti C.

Giorn Mal Inf Parass. 1981; 33(10): 1040 -1044

100) Eritromicina e Infezioni batteriche respiratorie: sensibilità in vitro ed in vivo

Mascellino M.T., Bollino D., Latella C.

Giorn Mal Inf Parass .1981; 33(10): 1045 -1048

101) Le sepsi anaerobiche in chirurgia d’urgenza

Chirletti P., Sarrao E., Mascellino MT., Rocco C., Basoli A:

J Antimicrob Chemother. 1981, 1: 47-55 ISSN 0305-7453

102) Resistance in anaerobic bacteria. Based on a symposium held at the 12th International

Congress of Chemotherapy Florence, 22 July 1981. Mascellino MT., Bollino D., Panichi G.

J Antimicrob Chemother 1981 Dec;8 Suppl D:1-132. PMID: 7338484

Page 13: Europass - uniroma1.it...Moretti C, Vullo V, Visca P, Venditti M. BMC Infect Dis. 2015 Sep 30;15:393. doi: 10.1186/s12879-015-1133-3.PMID:26424078 7 ) Therapeutic strategy for pandrug-resistant

Principal abstracts at International Conferences in the last years (2009-2015):

A. Oliva, F. Gizzi, A. D'Abramo, A. Cipolla, MT. Mascellino, C. M. Mastroianni, V. Vullo. In-Vivo

Efficacy and in-Vitro Activity of Double Carbapenem Regimen in Infections due to Carbapenem-

Resistant Klebsiella pneumoniae. Interscience Conference of Antimicrobial Agents and

Chemotherapy (ICAAC), 17-21 September 2015.

A Oliva, Nguyen BL, Cipolla A, Di Giamberardino A, A D’Abramo, Mascellino MT, S Poggi, M

Iannetta, Ciccaglioni A, Mastroianni CM, Vullo V. Detection of Cardiovascular Implantable

Electronic Device Infections with Sonication and Evaluation of Daptomicin and Rifampin Activity

Against Staphylococcus aureus Biofilms. Interscience Conference of Antimicrobial Agents and

Chemotherapy (ICAAC), 17-21 September 2015.

A. Oliva, M.T. Mascellino, A. Cipolla, F. Gizzi, A. D’Abramo, C.M. Mastroianni, V. Vullo.

Double-carbapenem therapy for systemic infections caused by carbapenemase-producing Klebsiella

pneumoniae. 25th European Congress of Clinical Microbriology and Infectious Diseases (ECCMID

2015), 25-28 April 2015.

Di Giamberardino AL, Nguyen BL, Oliva A, Mascellino MT, Cipolla A, Alessandri N, Gaudio C,

Ciccaglioni A, Mastroianni CM, Vullo V. MD.Detection of Cardiovascular Implantable Electronic

Device Infections with Sonication Following Lead Extraction and Generator Change. 36th Heart

Rhythm 2015. May 13-16, Boston.

Mascellino MT Activity of a double-carbapenem association in the in vitro susceptibility of

carbapenemase-producing klebsiella pneumoniae. OMICS Group Conferences Pathology 2015,

New-Orleans (Louisiana) USA 13-15 July

A. Oliva, B. Nguyen, A. Cipolla, M.T. Mascellino, R. Russo, A. D’Abramo, S. Nigro, A.L. Di

Giamberardino, A. Ciccaglioni, C.M. Mastroianni, V. Vullo. Role of sonication in the diagnosis and

pathogenesis of Cardiac Device Infections. MEETING OF ESCMID STUDY GROUP FOR

BIOFILMS (ESGB) Biofilm - based Healthcare - associated Infections: From Microbiology to

Clinics. 9-10 Ottobre 2014. IRCCS Fondazione Santa Lucia, Roma (Italy)

Oliva, A. Cipolla, A. D’Abramo, M.T. Mascellino, M. Iannetta, M. Pinnelli, C.M. Mastroianni, V.

Vullo. Study of Antimicrobial Combinations Against Carbapenem-Resistant Klebsiella pneumoniae

(CR-Kp): Role of Double-Carbapenem Regimen. 54th ICAAC. Washington, 5-9 September 2014.

D’Abramo A., Oliva A., Mascellino M.T., D’Agostino C., Iannetta M., Gallinelli C., Mastroianni

C.M., Vullo V Effectiveness of double-carbapenem regimen in carbapenem and colistin resistant

Klebsiella pneumoniae bloodstream infections: correlation with in-vitro analysis. 24th

ECCMID,10-13, Barcelona. May 2014.

Oliva A., Nguyen B.L., Mascellino M.T., Riitano G., Cipolla A., D'Abramo A., Iannetta M.,

Mastroianni C.M., Vullo V Microbiological diagnosis in Cardiac Device Infections: the role of

sonication 24th ECCMID 2014, Barcelona (Spain), May 10-13

Mascellino M.T., Ghezzi M.C., Oliva A., Raponi G.M. Candida Bloodstream Infections: species

distribution and antifungal resistance in intensive care unit (ICU) and in non-ICU wards at

an University Hospital in Rome 24th ECCMID 2014, Barcelona (Spain), May 10-13

Mascellino MT Virulence determinants and antibiotic resistance of Helicobacter pylori isolated in

pluritreated patients in a Department of Infectious Diseases in Rome OMICS Group Conferences,

Pathology 2014, San Antonio (Texas) USA April 13-15

B.Porowska, A.Oliva, M.T.Mascellino, C.Severi, M.Carabotti, P.Trentino, E.M.Flati (2013).

The incidence of H.Pylori hetero-resistance and its impact on therapeutic outcome in

pangastritis patients who failed several eradication schedules. In: DIGESTIVE AND LIVER

DISEASE. vol. 45(S2), p. S151-S152, Bologna, 20-23 marzo

Page 14: Europass - uniroma1.it...Moretti C, Vullo V, Visca P, Venditti M. BMC Infect Dis. 2015 Sep 30;15:393. doi: 10.1186/s12879-015-1133-3.PMID:26424078 7 ) Therapeutic strategy for pandrug-resistant

Barbara Porowska, Fabrizio Cereatti, Paolo Trentino, Fulvio Baldi, Gianfranco Fanello,

Fausto Fiocca, Domenico Vitolo, MT. Mascellino (2013). “One Year Incidence Of Gastric

Dysplasia And Its Relation To H.Pylori Infection In 2.270 Consecutive Gastroscopies, In

Rome”. In: Abstract Book. p. 126, Verona, 19-22 giugno

Mascellino MT., Candida bloodstream infections: Species distribution and antifungal resistance

in general medicine wards and in intensive care units OMICS Group Conferences, Pathology 2013, Las Vegas (Nevada) USA August 5-6

Mascellino MT., Oliva A, Gallinelli C., Mastroianni C.M., Vullo V Incidence of candidaemia and

antifungal sensitivity in critically ill patients . OMICS Group Conferences, Pathology 2012,

Philadelphia USA, August 27-29

A. Oliva, B.L. Nguyen, M.T.Mascellino, M.Iannetta, A.D’Abramo, V.Malagnino, A.Ciccaglioni,

V.Vullo, C.M. Mastroianni. Sonication of Cardiac Devices and their Components: Microbiological

and Pathogenetic Implication in Cardiac Device Infections. IN: 52nd ICAAC (INTERSCIENCE

CONFERENCE ON ANTIMICROBIAL AGENTS AND CHEMOTHERAPY), San Francisco, 09-

12/09/2012.

A. Oliva, B. Nguyen, M.T. Mascellino, F. Chiarini, F. Mengoni, A. Ciccaglioni, F. Fattorini, A.

D'Abramo, M. Iannetta, C. M. Mastroianni, V. Vullo (2011). Sonication of explanted devices

improves the pathogen detection in cardiac device infections. IN: 22nd European Congress of

Clinical Microbiology and Infectious Diseases (ECCMID), London 31/3-3/4/2012.

A. Oliva, B.L. Nguyen, M.T. Mascellino, F. Chiarini, F. Mengoni, A. Ciccaglioni, F. Fattorini, P.

Pavone, V. Vullo, C.M. Mastroianni. (2011) Sonication of removed devices for microbiological

diagnosis of Cardiac Device Infections. IN: 51 ST ICAAC (INTERSCIENCE CONFERENCE ON

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY), CHICAGO 17-20/11/2011

Porowska B, Mascellino M.T,.Culasso F., Severi C: The challenge of Helicobacter pylori

eradication therapies based on antibiotic susceptibility testing in a highly selected group of

pangastritis patients. GUT 2011 (Abstract XIX UEGW Stockolm October 22-26)

Mascellino MT, Oliva A, Gallinelli C, Nicosia R, Chiarini F (2010). 'Incidence of

Candidaemia and antifungal sensitivity in critically ill patients patients.' IN: CLINICAL

MICROBIOLOGY AND INFECTION (CMI). ECCMID (EUROPEAN CONGRESS OF

CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES) Vienna, 10-13 April 2010,

VOL. 16 (2)

Mascellino MT., Oliva A, Notarnicola R, Gallinelli C, Chiarini F Prevalence of

methicillin-resistant Staphylococcus in an Infectious Diseases ward in Rome: Correlation

with vancomycin susceptibility. Zing bacterial Cell Biology Conference. Puerto Morelos

Mexico, 16-19 November 2010

Mascellino MT., Margani M, Hassemer M.P, Oliva A. (2009). 'Resistance to antibiotics of

Helicobacter pylori strains from patients after treatment failure.' IN: CLINICAL MICROBIOLOGY

AND INFECTION,. ECCMID, Helsinki, Finland, 16-19 May 2009, Vol. 15(4)

Porowska B. Vergari M., Coda S., Flati G., Mascellino MT Regimes and rates of

Helicobacter pylori eradication in the population of Romeand neighbouring area GUT

2005 October 16 , 54 (7) Abstract XIII UEGW Copenaghen

Page 15: Europass - uniroma1.it...Moretti C, Vullo V, Visca P, Venditti M. BMC Infect Dis. 2015 Sep 30;15:393. doi: 10.1186/s12879-015-1133-3.PMID:26424078 7 ) Therapeutic strategy for pandrug-resistant

Textbooks (Chapters, etc.)

1 Mascellino M. T. Micobatteriologia: Esame colturale Collana “Quaderni di

Microbiologia Clinica QMC” Biomedia 1999

2 Mascellino M.T. Oliva A., Porowska B.: “ Pre-endoscopy screening of Helicobacter

pylori infection: implication and advantages” Endoscopy Book 1 2013; ISBN 978-953-

51-1034-7 http://dx.doi.org/10.5772/52734

3 Mascellino M.T. Editor of the book “Bacterial and Mycotic Infection in immuno-

compromised hosts: microbiological and clinical aspects” Omics Group Incorporation,

2014, ISBN: 978-1-63278-005-8

4 Oliva A., Mascellino MT. Mastroianni CM Medical Device Pre- and post- implant

testing” (Epidemiologic and Infection Control Microbiology section, Section 13) in

CLINICAL MICROBIOLOGY PROCEDURES HANDBOOK, Fourth Edition 2014

(CMPH4)